目的 分析比较总额控制下的病种分值付费和单病种付费支付方式的应用效果。方法 回顾性分析2015年—2018年总额控制下病种分值付费和单病种付费模式下的平均住院费用、医保基金支出以及医保基金收入等基本情况,比对分析总额控制下单病种付费模式下与病种分值付费模式的总体运行效率。结果 2015年—2018年总额控制下病种分值付费情况存在轻微波动,但不出现明显上涨现象,稳定于9 000元左右的水平,并且总额控制下病种分值付费的医保基金结余率处于17%的水平,同时具有稳定的医保基金支出与医保基金收入水平。相比较总额控制下病种分值付费,单病种付费模式下的平均住院费用更高,且呈现出逐年增加的发展趋势;相比较2015年的平均住院费用,2018年平均住院费用高出500元。2015年—2018年总额控制下单病种付费的医保基金结余率具有较大波动,表示医保基金支出与医保基金收入水平不稳定。结论 总额控制下的病种分值付费模式具有明显的医疗费用以及医保基金费用支出控制效果,但同时也具有较大的基础投入水平以及较高管理成本等缺陷端,总额控制下的单病种付费模式具有方便管理的优势,但是在费用控制、病种涵盖等方面不如病种分值付费,总额控制下的单病种付费与病种分值付费各具优势和不足,需要依据区域情况,取长补短,因地制宜以及择优而用,确保健全医保支付方式。

Objective To analyze the application effect of the payment of disease type and the payment of single disease payment under the control of total amount. Methods A retrospective analysis of the basic hospitalization expenses, medical insurance fund expenditures and medical insurance fund income under the control of the total value of the disease and the single-income payment model under the total control from 2015 to 2018 were taken, and to have comparative analysis of the total control of the single disease overall operational efficiency of the payment model with the payment model. Results There was a slight fluctuation in the payment of disease value under the control of total amount from 2015 to 2018, but there was no obvious increase, which was stable at around 9 000 yuan, and the balance of medical insurance fund paid for the disease value under the total control was at 17% level and has both stable medical insurance fund expenditure and medical insurance fund income level. Compared with the total score control under the total amount control, the average hospitalization cost under the single disease payment mode was higher, and showed a trend of increasing year by year; compared with the average hospitalization cost in 2015, the average hospitalization cost in 2018 was higher, out of 500 yuan. From 2015 to 2018, the balance of the medical insurance fund paid for the control of the single disease had a large fluctuation, indicating that the medical insurance fund expenditure and the medical insurance fund income level were unstable. Conclusion The disease-based payment model under total control has obvious control effect of medical expenses and medical insurance fund expenses, but it also has a large basic input level and high management cost and other defects. The payment model has the advantage of convenient management, but it is not as good as the cost control and disease coverage, and the single disease payment and the disease value payment under the total control have their own advantages and disadvantages, which need to be based on the regional situation. We need to make use of the strengths and weaknesses, adapt to local conditions and choose the best, to ensure a sound medical insurance payment method.

       目的   分析广州市中医优势病种按病种分值付费政策实施效果，以期为完善广州市中医病种付费方式改革提供参考思路。方法   以广州市某三甲中医医院住院患者在政策实施前（n=6 057）及实施后（n=7 208）住院病历为研究样本，对医院次均住院医疗费用、中医综合治疗费占比、平均住院日进行两独立样本非参数检验等描述性统计分析。结果  政策实施后，住院人次增长19%，患者次均住院医疗费用下降7.02%（P＜0.001），中医综合治疗费用占比提升0.8%（P＞0.05），医疗机构平均住院日缩短0.63 d（P＜0.001），入组中医优势病种患者自费率较非入组的低，医疗机构总体病例组合指数下降，中医优势病种结算有盈余。结论  中医优势病种按病种分值付费政策有利于医保-患者-医院三方共赢；但中医优势病种入组率有待提高，建议加大对中医医疗机构的支持与助力；中医综合治疗费用占比提升不显著，建议完善中医治疗项目医疗服务价格动态调整机制；中医优势病种仅局限在住院，建议实现诊疗单元全覆盖。

       Objective  To discuss the correlation analysis of the hospitalization expenses of TCM dominant diseases under the DIP payment mode，and provide a reference for further promoting the reform of the payment mode of TCM dominant diseases in Guangzhou．Methods  The nonparametric test was used to analyze the number of inpatients，the average hospitalization cost，and the proportion of TCM comprehensive treatment on the data of inpatient records before and after the implementation of the TCM dominant diseases policy，the sample sizes were 6 057 and 7 028 respectively．Results  After the implementation of the TCM dominant diseases policy，there was a slight fluctuation in the number of inpatients from 6 057 to 7 208，the average hospitalization cost was decreased by 7.02%（P＜0.001），the proportion of TCM comprehensive treatment costs had an increase of 0.8%（P＞0.05），the average length of hospital stay was shorten by 0.63 days（P＜0.001），the self-expense  rate of the patients with the TCM dominant diseases of in the group was lower than that of the patients without the group，the total case mix index value of the hospital decreased，but there was a surplus on the group of TCM dominant diseases settlement．Conclusios  The policy is conducive to the tripartite win-win of medical insurance，patients and hospitals．However，the enrollment rate of TCM dominant diseases need to be improved，which is suggested to increase the support for TCM hospitals．The proportion of TCM comprehensive treatment has not increased significantly，so it is suggested to improve the dynamic adjustment mechanism of medical service price of TCM treatment items．The TCM dominant diseases are only limited to hospitalization，and it is recommended to achieve full coverage of diagnosis and treatment units．